Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Tissue Engineering and Regenerative Medicine"
DOI: 10.1002/term.2428
Abstract: Legislation for expeditedâapproval pathways and programmes for drugs, biologics or medical devices has been enacted for rapid commercialization of innovative products in the United States of America (USA) and the European Union (EU). However, less… read more here.
Keywords: medicine; expedited approval; legislation expedited; approval ... See more keywords